The global Herpes Simplex Virus Infections market size was valued at US$ 2.89 billion in 2024 and is projected to reach US$ 3.78 billion by 2030, at a CAGR of 4.6% during the forecast period 2024-2030.
United States Herpes Simplex Virus Infections market size was valued at US$ 945 million in 2024 and is projected to reach US$ 1.19 billion by 2030, at a CAGR of 3.9% during the forecast period 2024-2030.
Treatment market for infections caused by herpes simplex viruses, including oral and genital herpes.
High prevalence of HSV infections driving steady market growth. Development of novel antiviral therapies and vaccines. Increasing awareness and diagnosis rates for herpes infections.
Report Overview
This report provides a deep insight into the global Herpes Simplex Virus Infections market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Herpes Simplex Virus Infections Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Herpes Simplex Virus Infections market in any manner.
Global Herpes Simplex Virus Infections Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Admedus Limited
- Agenus Inc.
- Aicuris Anti-infective Cures Gmbh
- Asahi Kasei Corporation
- Chimerix Inc.
- Clinigen Group Plc
- Daewoong Pharmaceutical Co., Ltd.
- F. Hoffmann-la Roche Ltd.
- Glaxosmithkline Plc
- Maruho Co. Ltd.
- Merck
- Mylan
- Novartis
- Sanofi Pasteur
- Teva Pharmaceutical Industries Ltd.
Market Segmentation (by Type)
- General Treatment
- Antiviral Therapy
Market Segmentation (by Application)
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Herpes Simplex Virus Infections Market
- Overview of the regional outlook of the Herpes Simplex Virus Infections Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the
major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Herpes Simplex Virus Infections
1.2 Key Market Segments
1.2.1 Herpes Simplex Virus Infections Segment by Type
1.2.2 Herpes Simplex Virus Infections Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Herpes Simplex Virus Infections Market Overview
2.1 Global Market Overview
2.1.1 Global Herpes Simplex Virus Infections Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Herpes Simplex Virus Infections Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Herpes Simplex Virus Infections Market Competitive Landscape
3.1 Global Herpes Simplex Virus Infections Sales by Manufacturers (2019-2024)
3.2 Global Herpes Simplex Virus Infections Revenue Market Share by Manufacturers (2019-2024)
3.3 Herpes Simplex Virus Infections Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Herpes Simplex Virus Infections Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Herpes Simplex Virus Infections Sales Sites, Area Served, Product Type
3.6 Herpes Simplex Virus Infections Market Competitive Situation and Trends
3.6.1 Herpes Simplex Virus Infections Market Concentration Rate
3.6.2 Global 5 and 10 Largest Herpes Simplex Virus Infections Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Herpes Simplex Virus Infections Industry Chain Analysis
4.1 Herpes Simplex Virus Infections Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Herpes Simplex Virus Infections Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Herpes Simplex Virus Infections Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Herpes Simplex Virus Infections Sales Market Share by Type (2019-2024)
6.3 Global Herpes Simplex Virus Infections Market Size Market Share by Type (2019-2024)
6.4 Global Herpes Simplex Virus Infections Price by Type (2019-2024)
7 Herpes Simplex Virus Infections Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Herpes Simplex Virus Infections Market Sales by Application (2019-2024)
7.3 Global Herpes Simplex Virus Infections Market Size (M USD) by Application (2019-2024)
7.4 Global Herpes Simplex Virus Infections Sales Growth Rate by Application (2019-2024)
8 Herpes Simplex Virus Infections Market Segmentation by Region
8.1 Global Herpes Simplex Virus Infections Sales by Region
8.1.1 Global Herpes Simplex Virus Infections Sales by Region
8.1.2 Global Herpes Simplex Virus Infections Sales Market Share by Region
8.2 North America
8.2.1 North America Herpes Simplex Virus Infections Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Herpes Simplex Virus Infections Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Herpes Simplex Virus Infections Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Herpes Simplex Virus Infections Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Herpes Simplex Virus Infections Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Admedus Limited
9.1.1 Admedus Limited Herpes Simplex Virus Infections Basic Information
9.1.2 Admedus Limited Herpes Simplex Virus Infections Product Overview
9.1.3 Admedus Limited Herpes Simplex Virus Infections Product Market Performance
9.1.4 Admedus Limited Business Overview
9.1.5 Admedus Limited Herpes Simplex Virus Infections SWOT Analysis
9.1.6 Admedus Limited Recent Developments
9.2 Agenus Inc.
9.2.1 Agenus Inc. Herpes Simplex Virus Infections Basic Information
9.2.2 Agenus Inc. Herpes Simplex Virus Infections Product Overview
9.2.3 Agenus Inc. Herpes Simplex Virus Infections Product Market Performance
9.2.4 Agenus Inc. Business Overview
9.2.5 Agenus Inc. Herpes Simplex Virus Infections SWOT Analysis
9.2.6 Agenus Inc. Recent Developments
9.3 Aicuris Anti-infective Cures Gmbh
9.3.1 Aicuris Anti-infective Cures Gmbh Herpes Simplex Virus Infections Basic Information
9.3.2 Aicuris Anti-infective Cures Gmbh Herpes Simplex Virus Infections Product Overview
9.3.3 Aicuris Anti-infective Cures Gmbh Herpes Simplex Virus Infections Product Market Performance
9.3.4 Aicuris Anti-infective Cures Gmbh Herpes Simplex Virus Infections SWOT Analysis
9.3.5 Aicuris Anti-infective Cures Gmbh Business Overview
9.3.6 Aicuris Anti-infective Cures Gmbh Recent Developments
9.4 Asahi Kasei Corporation
9.4.1 Asahi Kasei Corporation Herpes Simplex Virus Infections Basic Information
9.4.2 Asahi Kasei Corporation Herpes Simplex Virus Infections Product Overview
9.4.3 Asahi Kasei Corporation Herpes Simplex Virus Infections Product Market Performance
9.4.4 Asahi Kasei Corporation Business Overview
9.4.5 Asahi Kasei Corporation Recent Developments
9.5 Chimerix Inc.
9.5.1 Chimerix Inc. Herpes Simplex Virus Infections Basic Information
9.5.2 Chimerix Inc. Herpes Simplex Virus Infections Product Overview
9.5.3 Chimerix Inc. Herpes Simplex Virus Infections Product Market Performance
9.5.4 Chimerix Inc. Business Overview
9.5.5 Chimerix Inc. Recent Developments
9.6 Clinigen Group Plc
9.6.1 Clinigen Group Plc Herpes Simplex Virus Infections Basic Information
9.6.2 Clinigen Group Plc Herpes Simplex Virus Infections Product Overview
9.6.3 Clinigen Group Plc Herpes Simplex Virus Infections Product Market Performance
9.6.4 Clinigen Group Plc Business Overview
9.6.5 Clinigen Group Plc Recent Developments
9.7 Daewoong Pharmaceutical Co., Ltd.
9.7.1 Daewoong Pharmaceutical Co., Ltd. Herpes Simplex Virus Infections Basic Information
9.7.2 Daewoong Pharmaceutical Co., Ltd. Herpes Simplex Virus Infections Product Overview
9.7.3 Daewoong Pharmaceutical Co., Ltd. Herpes Simplex Virus Infections Product Market Performance
9.7.4 Daewoong Pharmaceutical Co., Ltd. Business Overview
9.7.5 Daewoong Pharmaceutical Co., Ltd. Recent Developments
9.8 F. Hoffmann-la Roche Ltd.
9.8.1 F. Hoffmann-la Roche Ltd. Herpes Simplex Virus Infections Basic Information
9.8.2 F. Hoffmann-la Roche Ltd. Herpes Simplex Virus Infections Product Overview
9.8.3 F. Hoffmann-la Roche Ltd. Herpes Simplex Virus Infections Product Market Performance
9.8.4 F. Hoffmann-la Roche Ltd. Business Overview
9.8.5 F. Hoffmann-la Roche Ltd. Recent Developments
9.9 Glaxosmithkline Plc
9.9.1 Glaxosmithkline Plc Herpes Simplex Virus Infections Basic Information
9.9.2 Glaxosmithkline Plc Herpes Simplex Virus Infections Product Overview
9.9.3 Glaxosmithkline Plc Herpes Simplex Virus Infections Product Market Performance
9.9.4 Glaxosmithkline Plc Business Overview
9.9.5 Glaxosmithkline Plc Recent Developments
9.10 Maruho Co. Ltd.
9.10.1 Maruho Co. Ltd. Herpes Simplex Virus Infections Basic Information
9.10.2 Maruho Co. Ltd. Herpes Simplex Virus Infections Product Overview
9.10.3 Maruho Co. Ltd. Herpes Simplex Virus Infections Product Market Performance
9.10.4 Maruho Co. Ltd. Business Overview
9.10.5 Maruho Co. Ltd. Recent Developments
9.11 Merck
9.11.1 Merck Herpes Simplex Virus Infections Basic Information
9.11.2 Merck Herpes Simplex Virus Infections Product Overview
9.11.3 Merck Herpes Simplex Virus Infections Product Market Performance
9.11.4 Merck Business Overview
9.11.5 Merck Recent Developments
9.12 Mylan
9.12.1 Mylan Herpes Simplex Virus Infections Basic Information
9.12.2 Mylan Herpes Simplex Virus Infections Product Overview
9.12.3 Mylan Herpes Simplex Virus Infections Product Market Performance
9.12.4 Mylan Business Overview
9.12.5 Mylan Recent Developments
9.13 Novartis
9.13.1 Novartis Herpes Simplex Virus Infections Basic Information
9.13.2 Novartis Herpes Simplex Virus Infections Product Overview
9.13.3 Novartis Herpes Simplex Virus Infections Product Market Performance
9.13.4 Novartis Business Overview
9.13.5 Novartis Recent Developments
9.14 Sanofi Pasteur
9.14.1 Sanofi Pasteur Herpes Simplex Virus Infections Basic Information
9.14.2 Sanofi Pasteur Herpes Simplex Virus Infections Product Overview
9.14.3 Sanofi Pasteur Herpes Simplex Virus Infections Product Market Performance
9.14.4 Sanofi Pasteur Business Overview
9.14.5 Sanofi Pasteur Recent Developments
9.15 Teva Pharmaceutical Industries Ltd.
9.15.1 Teva Pharmaceutical Industries Ltd. Herpes Simplex Virus Infections Basic Information
9.15.2 Teva Pharmaceutical Industries Ltd. Herpes Simplex Virus Infections Product Overview
9.15.3 Teva Pharmaceutical Industries Ltd. Herpes Simplex Virus Infections Product Market Performance
9.15.4 Teva Pharmaceutical Industries Ltd. Business Overview
9.15.5 Teva Pharmaceutical Industries Ltd. Recent Developments
10 Herpes Simplex Virus Infections Market Forecast by Region
10.1 Global Herpes Simplex Virus Infections Market Size Forecast
10.2 Global Herpes Simplex Virus Infections Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Herpes Simplex Virus Infections Market Size Forecast by Country
10.2.3 Asia Pacific Herpes Simplex Virus Infections Market Size Forecast by Region
10.2.4 South America Herpes Simplex Virus Infections Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Herpes Simplex Virus Infections by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Herpes Simplex Virus Infections Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Herpes Simplex Virus Infections by Type (2025-2030)
11.1.2 Global Herpes Simplex Virus Infections Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Herpes Simplex Virus Infections by Type (2025-2030)
11.2 Global Herpes Simplex Virus Infections Market Forecast by Application (2025-2030)
11.2.1 Global Herpes Simplex Virus Infections Sales (K Units) Forecast by Application
11.2.2 Global Herpes Simplex Virus Infections Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Herpes Simplex Virus Infections Market Size Comparison by Region (M USD)
Table 5. Global Herpes Simplex Virus Infections Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Herpes Simplex Virus Infections Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Herpes Simplex Virus Infections Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Herpes Simplex Virus Infections Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Simplex Virus Infections as of 2022)
Table 10. Global Market Herpes Simplex Virus Infections Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Herpes Simplex Virus Infections Sales Sites and Area Served
Table 12. Manufacturers Herpes Simplex Virus Infections Product Type
Table 13. Global Herpes Simplex Virus Infections Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Herpes Simplex Virus Infections
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Herpes Simplex Virus Infections Market Challenges
Table 22. Global Herpes Simplex Virus Infections Sales by Type (K Units)
Table 23. Global Herpes Simplex Virus Infections Market Size by Type (M USD)
Table 24. Global Herpes Simplex Virus Infections Sales (K Units) by Type (2019-2024)
Table 25. Global Herpes Simplex Virus Infections Sales Market Share by Type (2019-2024)
Table 26. Global Herpes Simplex Virus Infections Market Size (M USD) by Type (2019-2024)
Table 27. Global Herpes Simplex Virus Infections Market Size Share by Type (2019-2024)
Table 28. Global Herpes Simplex Virus Infections Price (USD/Unit) by Type (2019-2024)
Table 29. Global Herpes Simplex Virus Infections Sales (K Units) by Application
Table 30. Global Herpes Simplex Virus Infections Market Size by Application
Table 31. Global Herpes Simplex Virus Infections Sales by Application (2019-2024) & (K Units)
Table 32. Global Herpes Simplex Virus Infections Sales Market Share by Application (2019-2024)
Table 33. Global Herpes Simplex Virus Infections Sales by Application (2019-2024) & (M USD)
Table 34. Global Herpes Simplex Virus Infections Market Share by Application (2019-2024)
Table 35. Global Herpes Simplex Virus Infections Sales Growth Rate by Application (2019-2024)
Table 36. Global Herpes Simplex Virus Infections Sales by Region (2019-2024) & (K Units)
Table 37. Global Herpes Simplex Virus Infections Sales Market Share by Region (2019-2024)
Table 38. North America Herpes Simplex Virus Infections Sales by Country (2019-2024) & (K Units)
Table 39. Europe Herpes Simplex Virus Infections Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Herpes Simplex Virus Infections Sales by Region (2019-2024) & (K Units)
Table 41. South America Herpes Simplex Virus Infections Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Herpes Simplex Virus Infections Sales by Region (2019-2024) & (K Units)
Table 43. Admedus Limited Herpes Simplex Virus Infections Basic Information
Table 44. Admedus Limited Herpes Simplex Virus Infections Product Overview
Table 45. Admedus Limited Herpes Simplex Virus Infections Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Admedus Limited Business Overview
Table 47. Admedus Limited Herpes Simplex Virus Infections SWOT Analysis
Table 48. Admedus Limited Recent Developments
Table 49. Agenus Inc. Herpes Simplex Virus Infections Basic Information
Table 50. Agenus Inc. Herpes Simplex Virus Infections Product Overview
Table 51. Agenus Inc. Herpes Simplex Virus Infections Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Agenus Inc. Business Overview
Table 53. Agenus Inc. Herpes Simplex Virus Infections SWOT Analysis
Table 54. Agenus Inc. Recent Developments
Table 55. Aicuris Anti-infective Cures Gmbh Herpes Simplex Virus Infections Basic Information
Table 56. Aicuris Anti-infective Cures Gmbh Herpes Simplex Virus Infections Product Overview
Table 57. Aicuris Anti-infective Cures Gmbh Herpes Simplex Virus Infections Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Aicuris Anti-infective Cures Gmbh Herpes Simplex Virus Infections SWOT Analysis
Table 59. Aicuris Anti-infective Cures Gmbh Business Overview
Table 60. Aicuris Anti-infective Cures Gmbh Recent Developments
Table 61. Asahi Kasei Corporation Herpes Simplex Virus Infections Basic Information
Table 62. Asahi Kasei Corporation Herpes Simplex Virus Infections Product Overview
Table 63. Asahi Kasei Corporation Herpes Simplex Virus Infections Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Asahi Kasei Corporation Business Overview
Table 65. Asahi Kasei Corporation Recent Developments
Table 66. Chimerix Inc. Herpes Simplex Virus Infections Basic Information
Table 67. Chimerix Inc. Herpes Simplex Virus Infections Product Overview
Table 68. Chimerix Inc. Herpes Simplex Virus Infections Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Chimerix Inc. Business Overview
Table 70. Chimerix Inc. Recent Developments
Table 71. Clinigen Group Plc Herpes Simplex Virus Infections Basic Information
Table 72. Clinigen Group Plc Herpes Simplex Virus Infections Product Overview
Table 73. Clinigen Group Plc Herpes Simplex Virus Infections Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Clinigen Group Plc Business Overview
Table 75. Clinigen Group Plc Recent Developments
Table 76. Daewoong Pharmaceutical Co., Ltd. Herpes Simplex Virus Infections Basic Information
Table 77. Daewoong Pharmaceutical Co., Ltd. Herpes Simplex Virus Infections Product Overview
Table 78. Daewoong Pharmaceutical Co., Ltd. Herpes Simplex Virus Infections Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Daewoong Pharmaceutical Co., Ltd. Business Overview
Table 80. Daewoong Pharmaceutical Co., Ltd. Recent Developments
Table 81. F. Hoffmann-la Roche Ltd. Herpes Simplex Virus Infections Basic Information
Table 82. F. Hoffmann-la Roche Ltd. Herpes Simplex Virus Infections Product Overview
Table 83. F. Hoffmann-la Roche Ltd. Herpes Simplex Virus Infections Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. F. Hoffmann-la Roche Ltd. Business Overview
Table 85. F. Hoffmann-la Roche Ltd. Recent Developments
Table 86. Glaxosmithkline Plc Herpes Simplex Virus Infections Basic Information
Table 87. Glaxosmithkline Plc Herpes Simplex Virus Infections Product Overview
Table 88. Glaxosmithkline Plc Herpes Simplex Virus Infections Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Glaxosmithkline Plc Business Overview
Table 90. Glaxosmithkline Plc Recent Developments
Table 91. Maruho Co. Ltd. Herpes Simplex Virus Infections Basic Information
Table 92. Maruho Co. Ltd. Herpes Simplex Virus Infections Product Overview
Table 93. Maruho Co. Ltd. Herpes Simplex Virus Infections Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Maruho Co. Ltd. Business Overview
Table 95. Maruho Co. Ltd. Recent Developments
Table 96. Merck Herpes Simplex Virus Infections Basic Information
Table 97. Merck Herpes Simplex Virus Infections Product Overview
Table 98. Merck Herpes Simplex Virus Infections Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Merck Business Overview
Table 100. Merck Recent Developments
Table 101. Mylan Herpes Simplex Virus Infections Basic Information
Table 102. Mylan Herpes Simplex Virus Infections Product Overview
Table 103. Mylan Herpes Simplex Virus Infections Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Mylan Business Overview
Table 105. Mylan Recent Developments
Table 106. Novartis Herpes Simplex Virus Infections Basic Information
Table 107. Novartis Herpes Simplex Virus Infections Product Overview
Table 108. Novartis Herpes Simplex Virus Infections Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Novartis Business Overview
Table 110. Novartis Recent Developments
Table 111. Sanofi Pasteur Herpes Simplex Virus Infections Basic Information
Table 112. Sanofi Pasteur Herpes Simplex Virus Infections Product Overview
Table 113. Sanofi Pasteur Herpes Simplex Virus Infections Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Sanofi Pasteur Business Overview
Table 115. Sanofi Pasteur Recent Developments
Table 116. Teva Pharmaceutical Industries Ltd. Herpes Simplex Virus Infections Basic Information
Table 117. Teva Pharmaceutical Industries Ltd. Herpes Simplex Virus Infections Product Overview
Table 118. Teva Pharmaceutical Industries Ltd. Herpes Simplex Virus Infections Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Teva Pharmaceutical Industries Ltd. Business Overview
Table 120. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 121. Global Herpes Simplex Virus Infections Sales Forecast by Region (2025-2030) & (K Units)
Table 122. Global Herpes Simplex Virus Infections Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Herpes Simplex Virus Infections Sales Forecast by Country (2025-2030) & (K Units)
Table 124. North America Herpes Simplex Virus Infections Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Herpes Simplex Virus Infections Sales Forecast by Country (2025-2030) & (K Units)
Table 126. Europe Herpes Simplex Virus Infections Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Herpes Simplex Virus Infections Sales Forecast by Region (2025-2030) & (K Units)
Table 128. Asia Pacific Herpes Simplex Virus Infections Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Herpes Simplex Virus Infections Sales Forecast by Country (2025-2030) & (K Units)
Table 130. South America Herpes Simplex Virus Infections Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Herpes Simplex Virus Infections Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Herpes Simplex Virus Infections Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Herpes Simplex Virus Infections Sales Forecast by Type (2025-2030) & (K Units)
Table 134. Global Herpes Simplex Virus Infections Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Herpes Simplex Virus Infections Price Forecast by Type (2025-2030) & (USD/Unit)
Table 136. Global Herpes Simplex Virus Infections Sales (K Units) Forecast by Application (2025-2030)
Table 137. Global Herpes Simplex Virus Infections Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Herpes Simplex Virus Infections
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Herpes Simplex Virus Infections Market Size (M USD), 2019-2030
Figure 5. Global Herpes Simplex Virus Infections Market Size (M USD) (2019-2030)
Figure 6. Global Herpes Simplex Virus Infections Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Herpes Simplex Virus Infections Market Size by Country (M USD)
Figure 11. Herpes Simplex Virus Infections Sales Share by Manufacturers in 2023
Figure 12. Global Herpes Simplex Virus Infections Revenue Share by Manufacturers in 2023
Figure 13. Herpes Simplex Virus Infections Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Herpes Simplex Virus Infections Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Herpes Simplex Virus Infections Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Herpes Simplex Virus Infections Market Share by Type
Figure 18. Sales Market Share of Herpes Simplex Virus Infections by Type (2019-2024)
Figure 19. Sales Market Share of Herpes Simplex Virus Infections by Type in 2023
Figure 20. Market Size Share of Herpes Simplex Virus Infections by Type (2019-2024)
Figure 21. Market Size Market Share of Herpes Simplex Virus Infections by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Herpes Simplex Virus Infections Market Share by Application
Figure 24. Global Herpes Simplex Virus Infections Sales Market Share by Application (2019-2024)
Figure 25. Global Herpes Simplex Virus Infections Sales Market Share by Application in 2023
Figure 26. Global Herpes Simplex Virus Infections Market Share by Application (2019-2024)
Figure 27. Global Herpes Simplex Virus Infections Market Share by Application in 2023
Figure 28. Global Herpes Simplex Virus Infections Sales Growth Rate by Application (2019-2024)
Figure 29. Global Herpes Simplex Virus Infections Sales Market Share by Region (2019-2024)
Figure 30. North America Herpes Simplex Virus Infections Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Herpes Simplex Virus Infections Sales Market Share by Country in 2023
Figure 32. U.S. Herpes Simplex Virus Infections Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Herpes Simplex Virus Infections Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Herpes Simplex Virus Infections Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Herpes Simplex Virus Infections Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Herpes Simplex Virus Infections Sales Market Share by Country in 2023
Figure 37. Germany Herpes Simplex Virus Infections Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Herpes Simplex Virus Infections Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Herpes Simplex Virus Infections Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Herpes Simplex Virus Infections Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Herpes Simplex Virus Infections Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Herpes Simplex Virus Infections Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Herpes Simplex Virus Infections Sales Market Share by Region in 2023
Figure 44. China Herpes Simplex Virus Infections Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Herpes Simplex Virus Infections Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Herpes Simplex Virus Infections Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Herpes Simplex Virus Infections Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Herpes Simplex Virus Infections Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Herpes Simplex Virus Infections Sales and Growth Rate (K Units)
Figure 50. South America Herpes Simplex Virus Infections Sales Market Share by Country in 2023
Figure 51. Brazil Herpes Simplex Virus Infections Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Herpes Simplex Virus Infections Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Herpes Simplex Virus Infections Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Herpes Simplex Virus Infections Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Herpes Simplex Virus Infections Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Herpes Simplex Virus Infections Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Herpes Simplex Virus Infections Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Herpes Simplex Virus Infections Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Herpes Simplex Virus Infections Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Herpes Simplex Virus Infections Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Herpes Simplex Virus Infections Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Herpes Simplex Virus Infections Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Herpes Simplex Virus Infections Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Herpes Simplex Virus Infections Market Share Forecast by Type (2025-2030)
Figure 65. Global Herpes Simplex Virus Infections Sales Forecast by Application (2025-2030)
Figure 66. Global Herpes Simplex Virus Infections Market Share Forecast by Application (2025-2030)
